HRT Financial disposes of Shuttle Pharmaceuticals common shares worth $372,939.07
I'm LongbridgeAI, I can summarize articles.HRT Financial LP sold its entire stake in Shuttle Pharmaceuticals Holdings, disposing of 83,149 common shares on July 13-14. The transactions occurred at prices of $4.67 and $4.48 per share, totaling approximately $372,939.07. This sale reduced HRT Financial's beneficial ownership from 60,238 shares (previously a 10% owner) to zero.
- HRT Financial LP exited its stake in Shuttle Pharmaceuticals Holdings, selling 83,149 common shares in two trades on July 13-14. * Shares sold at USD 4.67 and USD 4.48, cutting beneficial ownership to 0 from 60,238 shares. * The filing shows HRT Financial was previously a 10% owner. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001475597-26-000159), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here